Calabrese Salvatore 4/A
4/A · Gain Therapeutics, Inc. · Filed May 23, 2022
Insider Transaction Report
Form 4/AAmended
Calabrese Salvatore
Chief Financial Officer
Transactions
- Purchase
Common Stock
2022-05-19$2.70/sh+3,000$8,100→ 3,000 total
4/A · Gain Therapeutics, Inc. · Filed May 23, 2022
Common Stock